CytoMed Therapeutics Ltd

GDTC

Company Profile

  • Business description

    CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

  • Contact

    1 Commonwealth Lane
    No. 08-22 One Commonwealth
    Singapore149544
    SGP

    T: +65 62507738

    https://w2.cytomed.sg

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    42

Stocks News & Analysis

stocks

Nvidia dominance continues

Our view on the latest earnings report.
stocks

Chart of the Week: Recent selloffs in this ASX sector opens doors to opportunity

Ongoing rate hikes have investors spooked.
stocks

ASX dividend champions: Stocks, ETFs and LICs

Mark and Shani run through lessons for ASX stocks, ETFs and LICs that have delivered over the past decade.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,840.809.50-0.11%
CAC 408,086.0031.42-0.39%
DAX 4024,606.77130.47-0.53%
Dow JONES (US)50,353.77344.420.69%
FTSE 10010,443.4711.130.11%
HKSE25,386.52264.60-1.03%
NASDAQ26,315.5245.160.17%
Nikkei 22561,684.141,879.733.14%
NZX 50 Index12,878.07117.040.92%
S&P 5007,450.1317.160.23%
S&P/ASX 2008,621.706.30-0.07%
SSE Composite Index4,077.2884.91-2.04%

Market Movers